Accu-Sal HIV-1&2 Antibody Saliva Rapid Screen Test
It has been shown that the
acquired immunodeficiency syndrome (AIDS) is caused by viruses which are transmitted by sexual contact, transfusion, using contaminated blood products and sharing contaminated needles. HIV-1 and 2 viruses have been isolated from patients with AIDS and AIDS-related complex (ARC), high risk persons for AIDS. HIV-1/2 viruses deplete T helper cells, a subpopulation of T cells for body defense, thus causing AIDS patients to be susceptible to opportunistic infections and developing malignant tumors. The incidence of specific antibodies to HIV-1/2 is high in AIDS, ARC and persons with high risk for AIDS. The Accu-Sal™ HIV-1/2 Antibody Saliva Rapid Screen Test was designed to detect antibodies to HIV-1/2 in AIDS patients, ARC or high risk persons and identify any potential donors carrying these antibodies in specimens.
The Accu-Sal™ HIV-1/2 Antibody Saliva Rapid Screen Test is a chromatographic immunoassay for the detection of antibodies to HIV-1/2 in human saliva. HIV-1/2 antibodies with binding protein are precoated onto membrane as capture reagents in the Test region (T). During the testing, specimen is allowed to react with the colloidal gold reagents which have been labeled with HIV- 1/2 specific antigens. Antibodies to HIV-1/2, if present, will cause a pink-colored band to develop on the membrane in proportion to the amount of HIV-1/2 antibodies present in the saliva specimen. Absence of this pink colored band in the test region (T) suggests a negative result. To serve as a procedural control, a pink colored band in the control region (C) will always appear regardless of the presence or absence of antibodies to HIV-1/2 in human saliva